All the Active Ingredient Drugs
Pyrimidine Analogues. Cytarabine 20 mg/ml, 50 mg/ml. VIAL (ready for use): 1 x 100 mg (5 ml);
500 mg (10 ml); 1,000 mg (20 ml), 2,000
mg (40 ml). See lit.
Neoplastic dis.
C/I: Known hypersens. to drug, bone
marrow suppress.
Pyrimidine Analogues. Cytarabine 1g/Vial. VIAL: 1. Convent. dose: In the induct. ther. of acute non-lymphocyt. leukemia, the
usual cytarabine dose in comb. with
other anti-cancer drugs is 100 mg/
m2/d by cont. I.V. infus. (1st -7th d.) or
100 mg/m2 I.V. every 12 hrs. (1st -7th
d.). High dose: 2-3 g/m2 as an I.V. infus.
over 1-3 hors given every 12 hours for
2-6 d. with/ without addit. cancer
chemother. agents.
Induct. and mainten. remiss. in acute
myelocytic leukemia of adults & child.
Tmt. of other leukemias. See Lit.
C/I: Pts. with pre exist. drug induced
bone marrow suppres. unless the clin.
feels that such manage. offers the most
hopeful alternative for the pt.
Manag. of non malignant dis., except for
immunosuppress.Hypersens.
